All In MedTech

Device Trial Radar · NCT05977751

Prospective Multi-Center Trial for FemBloc Permanent Birth Control

FINALE: Prospective Multi-Center Trial for FemBloc INtratubal Occlusion for TranscervicAL PErmanent Birth Control

Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

573

Planned (sponsor's estimate)

Start

Oct 31, 2023

Primary completion

Dec 2029

Study completion Jun 2031

Sponsor

Lead sponsor
Femasys Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 4, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
Female only, from 21 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Prospective, multi-center, international, unblinded, single-arm trial of subjects undergoing FemBloc followed by ultrasound confirmation test.

Conditions

  • Contraception

Interventions

  • FemBlocDevice

    Treatment for women who desire non-surgical permanent birth control by occlusion of the fallopian tubes.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pregnancy RateTime frame: one (1) year

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • New Horizons Clinical Trials

    Chandler, Arizona · Recruiting

  • Stanford University

    Palo Alto, California · Recruiting

  • University of California Davis

    Sacramento, California · Recruiting

9 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.